GlucoTrack, Inc. (GCTK)

0.6100 +0.0700 (+12.96%) At close: 04:00PM EDT

GlucoTrack, Inc.

301 Route 17 North
Suite 800
Rutherford, NJ 07070
United States
201 842 7715
https://glucotrack.com

Sector(s): Healthcare
Industry: Medical Instruments & Supplies
Full Time Employees: 6

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Paul V. Goode Ph.D.	Chief Executive Officer	225k	N/A	1969
Mr. Mark Tapsak Ph.D.	Vice President of Technology	165k	N/A	1969
Ms. Drinda Benjamin	Vice President of Marketing	N/A	N/A	1976
Mr. James P. Thrower Ph.D.	Vice President of Engineering	230k	N/A	1970
Mr. Avner Gal MBA, MSc.EE	Co-Founder, Chairman Emeritus, Consultant and Member of Scientific & Clinical Advisory Board	187.39k	N/A	1954
Mr. David Malka BA	Co-Founder	191.86k	N/A	1965
Mr. James S. Cardwell	Chief Financial Officer	N/A	N/A	1961

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.

Corporate Governance

GlucoTrack, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.